With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.
14h
Pharmaceutical Technology on MSNGalderma enters fierce European atopic dermatitis market with Nemluvio approvalNemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
Nektar Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years ...
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled SAN FRANCISCO and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., ...
credit: Getty Images Swamy Venuturupalli, MD, and Beth Darnall, PhD, discuss the emerging field of digital therapeutics and their potential for managing chronic pain in rheumatic disease. Recent ...
These innovative treatments have come to offer effective alternatives for most contact dermatitis patients diagnosed as moderate to severe who do not show improvement from regular treatments.
Optimised final draft guidance published today recommends 12 SQ-HDM SLIT, also known as Acarizax and made by ALK-Abello, as an option for treating persistent moderate to severe house dust mite ...
Auto news: Mitsubishi to sit out Nissan and Honda merger. © 2025 Nine Entertainment Co.
Upon approval from our Institutional Review Board, we conducted a retrospective chart review of patients who had a diagnosis of CAD at the NYU Charles C. Harris Skin and Cancer Unit from 1993 to ...
Storm Éowyn will be a “dangerous, destructive” weather event and among the most severe storms Ireland has ever experienced, the chair of the National Emergency Co-ordination Group (NECG) ...
Anaphylaxis symptoms can appear within an hour of injection and may lead to severe conditions, including shock and death. Healthcare providers should inform patients of risks and monitor for ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results